EFI
ZVSA

EHP Funds Inc’s ZyVersa Therapeutics ZVSA Stock Holding History

EHP Funds Inc’s Portfolio ZVSA Stock Details ZVSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-49
Closed -$171K – 376
2022
Q3 		$171K Hold
49
– – 0.03% 215
2022
Q2 		$170K Hold
49
– – 0.03% 220
2022
Q1 		$170K Buy
+49
New +$170K 0.03% 232

Other funds holding ZVSA

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

EHP Funds Inc's ZVSA Position: Q4 2022 in Review

EHP Funds Inc sold out of ZyVersa Therapeutics (ZVSA) in Q4 2022, closing a stake of 49 shares — an estimated $171K sold.

EHP Funds Inc first reported a position in ZVSA in Q1 2022 and held it in 3 quarters. The position peaked at $171K in Q3 2022. 2 funds tracked by Wall St. Rank hold ZVSA as of Q4 2022.

  • EHP Funds Inc reported no remaining ZyVersa Therapeutics position as of Q4 2022 after selling out during the quarter.
  • EHP Funds Inc sold 49 ZyVersa Therapeutics shares in Q4 2022, an estimated $171K.
  • EHP Funds Inc first reported a position in ZyVersa Therapeutics in Q1 2022 and held it in 3 quarters.
  • EHP Funds Inc's ZyVersa Therapeutics position peaked at $171K in Q3 2022.
  • 2 funds tracked by Wall St. Rank held ZyVersa Therapeutics as of Q4 2022.

Based on EHP Funds Inc's 13F filing for Q4 2022, filed 14 Feb 2023.